目的观察供体白细胞输注(DL I)治疗急慢性白血病和多发性骨髓瘤的疗效和安全性。
Objective To observe the therapeutic efficacy and safety of donor leukocyte infusion (DLI) in acute, chronic leukemia and multiple myeloma.
结果表明，血清酸溶性蛋白测定在急慢性白血病、恶性淋巴瘤和多发性骨髓瘤的诊断和病情监测上有一定的临床实用价值。
The results indicate that S-ASP determination may have diagnostic and monitoring value on the patients with leukemia, malignant lymphoma and multiple myeloma.
应用推荐